查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585638

生物安全櫃市場：按類型、最終用戶分類 - 2025-2030 年全球預測

Biological Safety Cabinet Market by Type (Class I, Class II, Class III), End User (Academic & Research Organizations, Diagnostics & Testing Laboratories, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物安全櫃市場價值為4.5646億美元，預計2024年將達到4.9474億美元，複合年成長率為8.47%，到2030年將達到8.0693億美元。

研究實驗室 (BSC) 是一個封閉、通風的實驗室工作空間，旨在保護居住者和環境免受病原微生物的侵害，用於生物醫學、製藥和生物技術研究應用。平衡計分卡在確保實驗室、工業環境和醫療機構的生物安全和防止污染方面發揮重要作用，凸顯了對平衡計分卡的需求。應用和最終用途範圍廣泛，從研究機構和臨床實驗室到醫院和製藥公司，在 COVID-19 等全球健康威脅中，由於對嚴格安全標準的需求，其採用率不斷增加。影響 BSC 市場的關鍵成長要素包括感染疾病的增加、生物安全問題的增加以及有關實驗室工作人員安全的嚴格法規結構。改進的氣流系統和先進的過濾技術等技術進步，以及對研發和醫療基礎設施的投資增加，特別是在新興市場，提供了潛在的成長機會。然而，市場成長面臨初始成本高、維護要求複雜以及監管核准流程冗長等挑戰，可能會阻礙小型實驗室採用平衡計分卡。為了利用新的商機，企業可以專注於創新領域，例如開發節能模型、整合數位監控系統以及在設計和製造中探索環保材料。我們還可以透過促進與研究機構的夥伴關係和合作來推動創新解決方案。市場競爭溫和，主要參與企業不斷創新以維持其市場地位並遵守不斷變化的安全標準。希望發展業務的公司應該投資強大的研發策略，開拓新興市場，並提供客製化服務以滿足特定實驗室的要求。這種研究驅動的創新方法將有助於克服現有的市場挑戰，並有效滿足對生物安全櫃不斷成長的需求。

主要市場統計
基準年[2023] 4.5646億美元
預測年份 [2024] 4.9474 億美元
預測年份 [2030] 80693萬美元
複合年成長率（%） 8.47%

市場動態：揭示快速發展的生物安全櫃市場的關鍵市場洞察

供需的動態交互作用正在改變生物安全櫃市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 利好法規促進生物安全櫃在醫療產業的使用
    • 流行病和傳染病的風險增加
    • 生技藥品數量快速增加
  • 市場限制因素
    • 替代存儲
  • 市場機會
    • 生物製藥和製藥公司的研發活動增加
    • 生技藥品數量快速增加 發展中國家醫療基礎建設投資增加
  • 市場問題
    • 開發低成本、高品質的生物安全櫃

波特的五力：駕馭生物安全櫃市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物安全櫃市場的外部影響

外部宏觀環境因素在塑造生物安全櫃市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解生物安全櫃市場的競爭格局

生物安全櫃市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣生物安全櫃市場供應商的績效評估

FPNV定位矩陣是評估生物安全櫃市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製生物安全櫃市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物安全櫃市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 利好法規促進生物安全櫃在醫療產業的使用
      • 流行病和傳染病的風險增加
      • 生技藥品快速成長
    • 抑制因素
      • 替代儲物櫃
    • 機會
      • 生物製藥和製藥公司的研發活動增加
      • 生技藥品的快速成長增加了成長中經濟體對衛生基礎設施的投資
    • 任務
      • 開發低成本、高品質的生物安全櫃
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章生物安全櫃市場：依類型

  • 介紹
  • Ⅰ類
  • 二級
    • Ⅱ類A型
    • II 類 B 型
  • 三級

第7章生物安全櫃市場：依最終用戶分類

  • 介紹
  • 學術/研究機構
  • 診斷和測試實驗室
  • 製藥和生物製藥公司

第8章美洲生物安全櫃市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物安全櫃市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲生物安全櫃市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Air Science USA LLC by PyroGenesis Canada Inc.
  • Alpha Linear
  • Berner International GmbH
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • Esco Micro Pte. Ltd.
  • EuroClone SpA
  • Flow Sciences, Inc.
  • Germfree Laboratories, Inc.
  • Haier Biomedical
  • Kewaunee Scientific Corporation
  • Labconco Corporation
  • Stericox India Private Limited
  • The Baker Company
  • Thermo Fisher Scientific Inc.
  • TopAir Systems Inc.
Product Code: MRR-437D4595793A

The Biological Safety Cabinet Market was valued at USD 456.46 million in 2023, expected to reach USD 494.74 million in 2024, and is projected to grow at a CAGR of 8.47%, to USD 806.93 million by 2030.

A Biological Safety Cabinet (BSC) is an enclosed, ventilated lab workspace designed to protect both the user and the environment from pathogenic microorganisms, with applications spanning biomedical, pharmaceutical, and biotechnological research. The necessity of BSCs is underscored by their critical role in ensuring biosafety and preventing contamination in laboratories, industrial settings, and healthcare facilities. The application and end-use scope are vast, extending from research institutions and clinical laboratories to hospitals and pharmaceutical companies, with increasing adoption driven by the need for stringent safety standards amid global health threats like COVID-19. Significant growth factors influencing the BSC market include the rise of infectious diseases, escalating biosecurity concerns, and stringent regulatory frameworks regarding laboratory personnel safety. Technological advancements, such as improved airflow systems and advanced filtration technologies, offer potential growth opportunities, along with increased investment in R&D and healthcare infrastructure, particularly in emerging markets. However, market growth faces challenges such as high initial costs, complex maintenance requirements, and a lengthy approval process from regulatory bodies, which may deter small-scale labs from adopting BSCs. To capitalize on emerging opportunities, companies can focus on areas of innovation, such as developing energy-efficient models, integrating digital monitoring systems, and exploring eco-friendly materials in design and manufacturing. Encouraging partnerships and collaborations with research institutions can also drive forward innovative solutions. The market presents a moderately competitive landscape with key players consistently innovating to maintain market presence and comply with evolving safety standards. Enterprises aiming for business growth should invest in robust R&D strategies, tap into emerging markets, and offer customization to meet specific lab requirements. This research-centered innovation approach could help in overcoming the existing market challenges and cater to the growing biosafety cabinet demand effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 456.46 million
Estimated Year [2024] USD 494.74 million
Forecast Year [2030] USD 806.93 million
CAGR (%) 8.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Safety Cabinet Market

The Biological Safety Cabinet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Favorable regulations driving the use of biological safety cabinets in the healthcare industry
    • Increased risk of pandemics and communicable diseases
    • Rapid growth in the number of biologics
  • Market Restraints
    • Alternative containment cabinet
  • Market Opportunities
    • Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
    • Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
  • Market Challenges
    • Development of low cost high quality biological safety cabinets

Porter's Five Forces: A Strategic Tool for Navigating the Biological Safety Cabinet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Safety Cabinet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Safety Cabinet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Safety Cabinet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Safety Cabinet Market

A detailed market share analysis in the Biological Safety Cabinet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Safety Cabinet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Safety Cabinet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Safety Cabinet Market

A strategic analysis of the Biological Safety Cabinet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Cabinet Market, highlighting leading vendors and their innovative profiles. These include Air Science USA LLC by PyroGenesis Canada Inc., Alpha Linear, Berner International GmbH, Biobase Biodusty (Shandong), Co., Ltd., Esco Micro Pte. Ltd., EuroClone S.p.A., Flow Sciences, Inc., Germfree Laboratories, Inc., Haier Biomedical, Kewaunee Scientific Corporation, Labconco Corporation, Stericox India Private Limited, The Baker Company, Thermo Fisher Scientific Inc., and TopAir Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Cabinet Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Class I, Class II, and Class III. The Class II is further studied across Class II Type A and Class II Type B.
  • Based on End User, market is studied across Academic & Research Organizations, Diagnostics & Testing Laboratories, and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Favorable regulations driving the use of biological safety cabinets in the healthcare industry
      • 5.1.1.2. Increased risk of pandemics and communicable diseases
      • 5.1.1.3. Rapid growth in the number of biologics
    • 5.1.2. Restraints
      • 5.1.2.1. Alternative containment cabinet
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
      • 5.1.3.2. Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Development of low cost high quality biological safety cabinets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Safety Cabinet Market, by Type

  • 6.1. Introduction
  • 6.2. Class I
  • 6.3. Class II
    • 6.3.1. Class II Type A
    • 6.3.2. Class II Type B
  • 6.4. Class III

7. Biological Safety Cabinet Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Organizations
  • 7.3. Diagnostics & Testing Laboratories
  • 7.4. Pharmaceutical & Biopharmaceutical Companies

8. Americas Biological Safety Cabinet Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biological Safety Cabinet Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biological Safety Cabinet Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Air Science USA LLC by PyroGenesis Canada Inc.
  • 2. Alpha Linear
  • 3. Berner International GmbH
  • 4. Biobase Biodusty (Shandong), Co., Ltd.
  • 5. Esco Micro Pte. Ltd.
  • 6. EuroClone S.p.A.
  • 7. Flow Sciences, Inc.
  • 8. Germfree Laboratories, Inc.
  • 9. Haier Biomedical
  • 10. Kewaunee Scientific Corporation
  • 11. Labconco Corporation
  • 12. Stericox India Private Limited
  • 13. The Baker Company
  • 14. Thermo Fisher Scientific Inc.
  • 15. TopAir Systems Inc.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL SAFETY CABINET MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL SAFETY CABINET MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL SAFETY CABINET MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS & TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023